Literature DB >> 22797958

Etiology of Crohn's disease: many roads lead to autophagy.

Pierre Lapaquette1, Patrick Brest, Paul Hofman, Arlette Darfeuille-Michaud.   

Abstract

Crohn's disease is a complex multifactor diseases that occur in individuals with genetic predisposition in whom environmental and microbial triggers cause a deleterious chronic immune response. Susceptibility to Crohn's disease is influenced by common variants at many loci. Genetic studies have emphasized the role of host susceptibility in inflammatory bowel disease onset with the identification of about 100 risk loci, most of which encode proteins involved in immunity, host defense against microbes, and gut homeostasis. In this review, we focus on susceptibility genes related to autophagy in the etiology of Crohn's disease (CD) and their complex interplay with the gut microbiota, as illustrated by the relationship between immunity-related GTPase family M alleles, microRNA, and xenophagy in CD predisposition.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22797958     DOI: 10.1007/s00109-012-0934-8

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  70 in total

Review 1.  New global map of Crohn's disease: Genetic, environmental, and socioeconomic correlations.

Authors:  Michael Economou; Georgios Pappas
Journal:  Inflamm Bowel Dis       Date:  2008-05       Impact factor: 5.325

2.  Mitochondria-anchored receptor Atg32 mediates degradation of mitochondria via selective autophagy.

Authors:  Koji Okamoto; Noriko Kondo-Okamoto; Yoshinori Ohsumi
Journal:  Dev Cell       Date:  2009-07       Impact factor: 12.270

Review 3.  Genetics and pathogenesis of inflammatory bowel disease.

Authors:  Bernard Khor; Agnès Gardet; Ramnik J Xavier
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

4.  Risk predisposition for Crohn disease: a "ménage à trois" combining IRGM allele, miRNA and xenophagy.

Authors:  Patrick Brest; Pierre Lapaquette; Baharia Mograbi; Arlette Darfeuille-Michaud; Paul Hofman
Journal:  Autophagy       Date:  2011-07-01       Impact factor: 16.016

5.  Human IRGM induces autophagy to eliminate intracellular mycobacteria.

Authors:  Sudha B Singh; Alexander S Davis; Gregory A Taylor; Vojo Deretic
Journal:  Science       Date:  2006-08-03       Impact factor: 47.728

Review 6.  The role of bacteria and pattern-recognition receptors in Crohn's disease.

Authors:  Si Ming Man; Nadeem O Kaakoush; Hazel M Mitchell
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-02-08       Impact factor: 46.802

Review 7.  Pathogenic agents in inflammatory bowel diseases.

Authors:  Guillaume Pineton de Chambrun; Jean-Frédéric Colombel; Daniel Poulain; Arlette Darfeuille-Michaud
Journal:  Curr Opin Gastroenterol       Date:  2008-07       Impact factor: 3.287

8.  Escherichia coli isolated from a Crohn's disease patient adheres, invades, and induces inflammatory responses in polarized intestinal epithelial cells.

Authors:  Tonyia Eaves-Pyles; Christopher A Allen; Joanna Taormina; Alexander Swidsinski; Christopher B Tutt; G Eric Jezek; Martha Islas-Islas; Alfredo G Torres
Journal:  Int J Med Microbiol       Date:  2007-09-27       Impact factor: 3.473

9.  Use of sirolimus (rapamycin) to treat refractory Crohn's disease.

Authors:  D C O Massey; F Bredin; M Parkes
Journal:  Gut       Date:  2008-09       Impact factor: 23.059

10.  CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease.

Authors:  Nicolas Barnich; Frédéric A Carvalho; Anne-Lise Glasser; Claude Darcha; Peter Jantscheff; Matthieu Allez; Harald Peeters; Gilles Bommelaer; Pierre Desreumaux; Jean-Frédéric Colombel; Arlette Darfeuille-Michaud
Journal:  J Clin Invest       Date:  2007-05-24       Impact factor: 14.808

View more
  11 in total

Review 1.  Biological pathways involved in the development of inflammatory bowel disease.

Authors:  Mateja Zemljic; Bozena Pejkovic; Ivan Krajnc; Saska Lipovsek
Journal:  Wien Klin Wochenschr       Date:  2014-09-26       Impact factor: 1.704

2.  Serum protein profiling of adults and children with Crohn disease.

Authors:  Anna Vaiopoulou; Maria Gazouli; Aggeliki Papadopoulou; Athanassios K Anagnostopoulos; George Karamanolis; George E Theodoropoulos; Amosy M'Koma; George T Tsangaris
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-01       Impact factor: 2.839

3.  Mesenchymal Stromal Cells Derived From Crohn's Patients Deploy Indoleamine 2,3-dioxygenase-mediated Immune Suppression, Independent of Autophagy.

Authors:  Raghavan Chinnadurai; Ian B Copland; Spencer Ng; Marco Garcia; Mahadev Prasad; Dalia Arafat; Greg Gibson; Subra Kugathasan; Jacques Galipeau
Journal:  Mol Ther       Date:  2015-04-22       Impact factor: 11.454

4.  Increased viability but decreased culturability of Mycobacterium avium subsp. paratuberculosis in macrophages from inflammatory bowel disease patients under Infliximab treatment.

Authors:  Nair Nazareth; Fernando Magro; Rui Appelberg; Jani Silva; Daniela Gracio; Rosa Coelho; José Miguel Cabral; Candida Abreu; Guilherme Macedo; Tim J Bull; Amélia Sarmento
Journal:  Med Microbiol Immunol       Date:  2015-02-22       Impact factor: 3.402

5.  Selective autophagy: xenophagy.

Authors:  Kyle A Bauckman; Nana Owusu-Boaitey; Indira U Mysorekar
Journal:  Methods       Date:  2014-12-11       Impact factor: 3.608

6.  Late-Onset Crohn's Disease Is A Subgroup Distinct in Genetic and Behavioral Risk Factors With UC-Like Characteristics.

Authors:  Dalin Li; Talin Haritunians; Carol Landers; Alka A Potdar; Shaohong Yang; Hailiang Huang; L Philip Schumm; Mark Daly; Stephan R Targan; Dermot P B McGovern
Journal:  Inflamm Bowel Dis       Date:  2018-10-12       Impact factor: 5.325

7.  Specific detection of OCT4 isoforms in inflammatory bowel disease.

Authors:  Maria Maragkoudaki; Anna Vaiopoulou; George E Theodoropoulos; Evangelia Legaki; Leonardo A Sechi; George Karamanolis; George Zografos; Maria Gazouli
Journal:  Gut Pathog       Date:  2015-10-01       Impact factor: 4.181

Review 8.  From single nucleotide polymorphisms to constant immunosuppression: mesenchymal stem cell therapy for autoimmune diseases.

Authors:  Raghavan Chinnadurai; Edmund K Waller; Jacques Galipeau; Ajay K Nooka
Journal:  Biomed Res Int       Date:  2013-11-19       Impact factor: 3.411

9.  The T300A Crohn's disease risk polymorphism impairs function of the WD40 domain of ATG16L1.

Authors:  Emilio Boada-Romero; Inmaculada Serramito-Gómez; María P Sacristán; David L Boone; Ramnik J Xavier; Felipe X Pimentel-Muiños
Journal:  Nat Commun       Date:  2016-06-08       Impact factor: 14.919

Review 10.  Dietary interactions with the bacterial sensing machinery in the intestine: the plant polyphenol case.

Authors:  Noha Ahmed Nasef; Sunali Mehta; Lynnette R Ferguson
Journal:  Front Genet       Date:  2014-04-04       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.